NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fourth quarter revenues rose 3 percent, driven by strong growth in sales within its gynecology surgical and molecular diagnostics businesses.

For the three months ended September 30, the firm reported revenues of $726.8 million up from $702.8 million a year ago, and beating the average consensus Wall Street estimate of $721.7 million. On a constant-currency basis, revenues increased 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.